Precision Diagnostics Integrity Laboratories specializes in high complexity molecular diagnostics and precision medicine, presenting an opportunity to position their tests with payer networks and healthcare systems seeking advanced diagnostic capabilities to improve patient outcomes and reduce total costs.

Quantitative Capabilities Their milestone of launching a quantitative COVID-19 test signals a strength in providing measurable, data-driven results. Sales outreach can target clinical laboratories and hospital networks prioritizing quantitative surveillance and outcome tracking.

Oral Specimen Advantage The Proliva DX oral saliva testing line offers a patient-friendly alternative to nasopharyngeal swabs, enabling outreach to ambulatory clinics and primary care networks focused on patient comfort, compliance, and expanded testing access.

Strategic Partnerships Current collaborations with trusted providers, healthcare systems, and payer networks indicate opportunities to expand through system-level contracts, reference lab agreements, and integrated diagnostics programs across regional networks.

Growth and Platform The launch of Intercept PCR platform and a sophisticated testing platform suggests a capability to scale with feature-rich offerings. Target growth-stage hospitals, regional labs, and specialty clinics seeking scalable, high-complexity diagnostics.